Today: 8 June 2026
Ameren Holders Approve CEO Compensation, $14 Million Package Not Unanimous
19 May 2026
2 mins read

Ameren Holders Approve CEO Compensation, $14 Million Package Not Unanimous

ST. LOUIS, May 19, 2026, 03:04 CDT

  • Ameren investors signed off on executive pay, re-elected the full board, and kept PwC as auditor.
  • CEO Martin J. Lyons, Jr.’s total pay for 2025 hit $14.06 million, according to the disclosure that came before the vote.
  • The issue comes up while the regulated utility is pouring money into infrastructure and still waiting for important rate and regulatory decisions.

Ameren Corporation shareholders backed executive pay and kept all 12 directors in place, handing the St. Louis-based utility’s management a win just after results from its annual meeting were filed with U.S. securities regulators. The support came after Ameren said Chief Executive Martin J. Lyons, Jr. got $14.06 million in total compensation for 2025, up from $9.73 million the year before.

Ameren wants investors to support its capital-intensive strategy as the vote comes up, with more grid upgrades, more gas-system projects, and heavier regulatory scrutiny over who pays. The company said first-quarter earnings got a lift from infrastructure spending, and it kept 2026 earnings guidance at $5.25 to $5.45 a share.

Ameren shares traded at $107.38, gaining $1.02 on the day, market data showed. Goldman Sachs’s Carly Davenport maintained her Hold call and $113 price target this month. TipRanks said Davenport’s view was based on strong demand, balanced by ongoing regulatory questions in Illinois and Missouri.

The “say-on-pay” resolution, which gives shareholders a nonbinding vote on executive pay, got 208,210,735 votes for and 9,383,298 against. There were 951,507 abstentions. Broker non-votes came in at 24,519,860 shares.

Ameren’s board nominees were all elected. Steven H. Lipstein saw the most votes against, picking up 14,096,981. Jamie L. Engstrom had the strongest backing, getting 216,191,429 votes in support.

Shareholders approved PricewaterhouseCoopers LLP as auditor through Dec. 31, 2026. The vote was 232,732,466 in favor and 9,840,141 against. Over at the utility arms, Ameren Missouri and Ameren Illinois re-elected their five-member boards, and the company said there were no withheld votes, abstentions or broker non-votes.

Ameren’s proxy listed CEO Marty Lyons’ 2025 pay as $1.33 million in salary, $8.21 million in stock awards, plus $3.33 million in non-equity incentives. The company reported a median worker pay of $125,070, setting the CEO pay ratio at 112 to 1. Other pay for Lyons included $184,185 for personal flights under a board security and business travel policy.

Lyons is calling the spending plan a reliability matter. “Customers depend on us every day for safe, reliable, and affordable energy—and demand is growing,” he said with Ameren’s first-quarter report. He said meeting those needs takes “disciplined ongoing infrastructure investment.” Ameren Investors

Ameren bases its pay structure on other U.S. regulated utilities, saying its 2025 compensation peer group features Duke Energy, DTE Energy and Xcel Energy. Ameren said data from those utility peers guides its executive pay decisions.

The vote leaves Ameren’s biggest risk in place. Regulators, courts or lawmakers still have the power to limit how much Ameren can charge customers for investment costs. The company has warned that pending Illinois rate cases and federal transmission appeals could affect its results.

Ameren cleared its shareholder meeting with no changes to the board, kept its auditor, and got solid support for its pay package. There was some opposition, but the votes were not close. The bigger challenge for Ameren is outside the meeting, where regulators and spending decisions will drive customer bills, earnings and investor sentiment.

Stock Market Today

  • Micron Investment: $1000 Ten Years Ago Would Have Grown Significantly
    June 8, 2026, 10:10 AM EDT. Investing $1000 in Micron Technology (MU) a decade ago would have yielded substantial returns. Micron, a leading global semiconductor memory solutions provider, reported $15.54 billion in fiscal 2023 revenues. Its business is divided into four segments: Compute and Networking, Mobile, Storage, and Embedded units, with DRAM sales forming a major revenue source. Despite fierce competition from Intel, Samsung, and others, Micron's diverse product portfolio supports growth. This example underlines the importance of long-term investment, patience, and market research in building a profitable portfolio.

Latest articles

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

8 June 2026
Amazon’s new multibillion-dollar supply deal makes Corning a key fiber provider for U.S. data centers, but with shares up 305% in 12 months and investors already pricing in big AI wins, the stock was little changed at $177.58 premarket as risks of factory delays and high expectations loom.
BlackBerry Shares Stall After QNX Push

BlackBerry Stock Moves in Pre-Market Ahead of June Test

8 June 2026
BlackBerry’s U.S. shares rose 2.34% in premarket trading to $9.63 after Friday’s 8.99% drop, but with analyst targets averaging just $4.98, investors are betting on QNX growth and secure-communications wins ahead of June 25 earnings; any disappointment could hit the stock hard.
Micron Technology Stock Surges as AI Memory Shortage Puts MU at Center of Chip Rally

Micron Shares Edge Up in Premarket; Investors Await Next AI Test

8 June 2026
Micron surged 8.2% to $935.07 in Nasdaq premarket after Friday’s $127 billion rout, as investors cheered Nvidia’s confirmation it will keep sourcing high-bandwidth memory from Micron and Samsung, easing fears SK Hynix would become exclusive supplier; Cantor Fitzgerald raised its price target to $1,500, with Micron’s next earnings report due June 24.
Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

8 June 2026
Tango shares soared up to 48% in premarket trading after reporting a 92% objective response rate and 90% six-month progression-free survival in a 12-patient pancreatic cancer trial, with plans to advance the vopimetostat-daraxonrasib combo to Phase 3 testing in first-line MTAP-deleted pancreatic cancer.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

US Stock Market Today: Live Updates 19.05.2026

Nasdaq Futures Slip Pre-Nvidia Results
Next Story

Nasdaq Futures Slip Pre-Nvidia Results

Go toTop